1. Home
  2. SLXN vs MFI Comparison

SLXN vs MFI Comparison

Compare SLXN & MFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLXN
  • MFI
  • Stock Information
  • Founded
  • SLXN 2008
  • MFI 2002
  • Country
  • SLXN Israel
  • MFI Hong Kong
  • Employees
  • SLXN N/A
  • MFI N/A
  • Industry
  • SLXN
  • MFI
  • Sector
  • SLXN
  • MFI
  • Exchange
  • SLXN NYSE
  • MFI NYSE
  • Market Cap
  • SLXN 5.0M
  • MFI 9.9M
  • IPO Year
  • SLXN N/A
  • MFI 2024
  • Fundamental
  • Price
  • SLXN $1.08
  • MFI $0.65
  • Analyst Decision
  • SLXN Strong Buy
  • MFI
  • Analyst Count
  • SLXN 1
  • MFI 0
  • Target Price
  • SLXN $9.00
  • MFI N/A
  • AVG Volume (30 Days)
  • SLXN 31.3M
  • MFI 285.6K
  • Earning Date
  • SLXN 02-25-2025
  • MFI 02-24-2025
  • Dividend Yield
  • SLXN N/A
  • MFI N/A
  • EPS Growth
  • SLXN N/A
  • MFI N/A
  • EPS
  • SLXN N/A
  • MFI N/A
  • Revenue
  • SLXN N/A
  • MFI $3,877,747.00
  • Revenue This Year
  • SLXN N/A
  • MFI N/A
  • Revenue Next Year
  • SLXN N/A
  • MFI N/A
  • P/E Ratio
  • SLXN N/A
  • MFI N/A
  • Revenue Growth
  • SLXN N/A
  • MFI N/A
  • 52 Week Low
  • SLXN $0.21
  • MFI $0.51
  • 52 Week High
  • SLXN $13.56
  • MFI $14.49
  • Technical
  • Relative Strength Index (RSI)
  • SLXN N/A
  • MFI N/A
  • Support Level
  • SLXN N/A
  • MFI N/A
  • Resistance Level
  • SLXN N/A
  • MFI N/A
  • Average True Range (ATR)
  • SLXN 0.00
  • MFI 0.00
  • MACD
  • SLXN 0.00
  • MFI 0.00
  • Stochastic Oscillator
  • SLXN 0.00
  • MFI 0.00

About SLXN BIOMOTION SCIENCES

Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.

About MFI MF INTERNATIONAL LIMITED

mF International Ltd is a holding company and all of its operations are carried out by Operating Subsidiaries in Hong Kong. It is a financial trading solution provider principally engaged in the development and provision of financial trading solutions. It has experience in providing real-time mission-critical forex, bullion/commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company has provided a wide range of top-notch services, including mF4 Trading Platform, Bridge and Plugins, CRM System, ECN System, Liquidity Solutions, Cross-platform Broker Plus Solution, Social Trading Applications and others.

Share on Social Networks: